journal article·2025-03Open access

Spleen‐Targeted mRNA Nanoparticles for Modulating B Cell Hyperactivation in Rheumatoid Arthritis Therapy

Yanpeng Liu, Runnan Zhang, Nasha Qiu, Shuai Wang, Jian Chen, Xiao Xu, Jiajia Xiang, Youqing Shen

Advanced Functional Materials· Volume 35· Issue 11

Abstract

Abstract Messenger RNA (mRNA)‐based therapies have emerged as a revolutionary strategy for treating various diseases. In autoimmune diseases like rheumatoid arthritis (RA), targeted mRNA delivery provides a potential intervention to modulate immune responses. However, achieving specific and efficient in vivo modulation of immune regulators, such as the inhibitory Fc gamma receptor, FcγRIIB, on B cells remains challenging. In this study, lipid polymer nanoparticles (LPNs) formulated with AMB‐POC18 lipidoid and poly(ethylene glycol)‐block‐polylactide (PEG‐PLA) are engineered to deliver FcγRIIB mRNA (mFcγRIIB) specifically to splenic B cells for RA treatment. Protein corona analysis indicated that selective adsorption of complement C3 on the LPNs' surface facilitated their targeted delivery to the spleen, enhancing transfection efficiency in B cells following intravenous administration. In a collagen‐induced arthritis mouse model, mFcγRIIB/LPNs effectively upregulated FcγRIIB expression in splenic B cells, significantly reducing autoimmune responses and alleviating RA symptoms. Further mechanistic studies elucidated that increased FcγRIIB expression suppressed B cell activation via the FcγRIIB/Lyn/SHP‐1 signaling pathway. This work underscored the potential of the spleen‐targeted mRNA delivery system for RA therapy, providing a precise and targeted approach to modulate B cell activity and mitigate autoimmune diseases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Monoclonal and Polyclonal Antibodies Research · CAR-T cell therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering College of Chemical and Biological Engineering Key Laboratory of Biomass Chemical Engineering of the Ministry of Education College of Chemical and Biological Engineering Zhejiang University Hangzhou 310058 China

Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province Affiliated Hangzhou First People's Hospital School of Medicine Westlake University Hangzhou 310006 China

Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery Zhejiang Provincial People's Hospital (Affiliated People's Hospital) School of Clinical Medicine Hangzhou Medical College Hangzhou 310024 China

Institute of Translational Medicine Zhejiang University School of Medicine Hangzhou 310000 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1002/EXP.2023016510.1002/EXP.20230165 ↗
2. 10.1038/s41573-021-00283-510.1038/s41573-021-00283-5 ↗
3. 10.1016/j.addr.2020.12.01410.1016/j.addr.2020.12.014 ↗
4. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
5. 10.1021/acs.accounts.1c0054410.1021/acs.accounts.1c00544 ↗
6. 10.1038/s41467-022-32281-510.1038/s41467-022-32281-5 ↗
7. 10.1038/nnano.2017.5210.1038/nnano.2017.52 ↗
8. 10.1038/s41565-023-01453-910.1038/s41565-023-01453-9 ↗
9. 10.1073/pnas.211627111910.1073/pnas.2116271119 ↗
10. 10.1038/s41565-020-0669-610.1038/s41565-020-0669-6 ↗
11. 10.1056/NEJMra203534310.1056/NEJMra2035343 ↗
12. 10.1038/s41563-020-00886-010.1038/s41563-020-00886-0 ↗
13. 10.1038/s41467-024-50093-710.1038/s41467-024-50093-7 ↗
14. 10.1007/s10118-018-2078-y10.1007/s10118-018-2078-y ↗
15. 10.1016/j.jconrel.2022.03.03310.1016/j.jconrel.2022.03.033 ↗
16. 10.1002/adfm.20230379510.1002/adfm.202303795 ↗
17. 10.1016/S0140-6736(23)01525-810.1016/S0140-6736(23)01525-8 ↗
18. 10.1001/jama.2022.078610.1001/jama.2022.0786 ↗
19. 10.1186/s12943-018-0779-z10.1186/s12943-018-0779-z ↗
20. 10.1056/NEJMoa03253410.1056/NEJMoa032534 ↗
21. 10.1038/s41583-019-0233-210.1038/s41583-019-0233-2 ↗
22. 10.1016/j.autrev.2022.10311610.1016/j.autrev.2022.103116 ↗
23. 10.1016/j.immuni.2023.02.01910.1016/j.immuni.2023.02.019 ↗
24. 10.1038/s41581-023-00720-110.1038/s41581-023-00720-1 ↗
25. 10.3390/ijms2302090510.3390/ijms23020905 ↗
26. 10.1126/science.aap931010.1126/science.aap9310 ↗
27. 10.1038/s41573-020-00092-210.1038/s41573-020-00092-2 ↗
28. 10.1038/nri276210.1038/nri2762 ↗
29. 10.1038/nri282110.1038/nri2821 ↗
30. 10.4049/jimmunol.090233410.4049/jimmunol.0902334 ↗
31. 10.1172/JCI15725010.1172/JCI157250 ↗
32. 10.1021/acsnano.8b0878510.1021/acsnano.8b08785 ↗
33. 10.1038/s41467-021-22454-z10.1038/s41467-021-22454-z ↗
34. 10.3390/ijms2408762310.3390/ijms24087623 ↗
35. 10.1016/j.imlet.2014.08.01610.1016/j.imlet.2014.08.016 ↗
36. Zhang R. N. · Adv. Mater. · 2023 · 35
37. 10.1021/acs.accounts.9b0022810.1021/acs.accounts.9b00228 ↗
38. 10.3390/ijms2503173910.3390/ijms25031739 ↗
39. 10.1038/s41565-021-00858-810.1038/s41565-021-00858-8 ↗
40. 10.1016/j.jtauto.2020.10007510.1016/j.jtauto.2020.100075 ↗
41. 10.1002/adma.20230250310.1002/adma.202302503 ↗
42. 10.1126/science.abf747010.1126/science.abf7470 ↗
43. 10.1038/s41467-022-31882-410.1038/s41467-022-31882-4 ↗
44. 10.1038/s41467-020-16248-y10.1038/s41467-020-16248-y ↗
45. 10.4049/jimmunol.160127110.4049/jimmunol.1601271 ↗
46. 10.1016/j.toxicon.2010.04.00710.1016/j.toxicon.2010.04.007 ↗
47. 10.1084/jem.2007256510.1084/jem.20072565 ↗
48. 10.3390/cells1121339110.3390/cells11213391 ↗
49. 10.1016/j.jconrel.2024.05.00710.1016/j.jconrel.2024.05.007 ↗
50. 10.1111/imr.1236810.1111/imr.12368 ↗
51. 10.1016/j.autrev.2016.07.03510.1016/j.autrev.2016.07.035 ↗
52. Kim K. J. · Immunology · 1986 · 59 · 15
53. 10.1016/j.matt.2023.12.02210.1016/j.matt.2023.12.022 ↗
54. 10.3389/fimmu.2021.75075310.3389/fimmu.2021.750753 ↗
55. 10.1016/S1074-7613(00)80074-610.1016/S1074-7613(00)80074-6 ↗
56. 10.1016/j.biopha.2020.11116610.1016/j.biopha.2020.111166 ↗
57. 10.1093/intimm/10.2.14110.1093/intimm/10.2.141 ↗